Work

Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) study

Year: 2022

Type: article

Study design: Observational Study

Source: American Journal of Obstetrics and Gynecology

DOI: 10.1016/j.ajog.2022.12.009

Authors: Michael Frumovitz, Gary B. Chisholm, Anuja Jhingran, Preetha Ramalingam, Alejandra Flores-Legarreta, Priya Bhosale, Naomi R. Gonzales, R. Tyler Hillman, Gloria Salvo

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, GlaxoSmithKline, University of Texas MD Anderson Cancer Center, National Cancer Institute

Award: G111615301

OpenAlex ID: W4311127372

FWCI: 5.385

Cites: 28

Cited by: 27

Related to: 10